Indian pharma stocks are in focus as the country prepares to expand exports to Russia, Brazil, and the Netherlands, reducing reliance on the US, which takes 35% of its drug shipments. While Indian pharma exports surged 20% to $10.5 billion in FY25, reports of possible US tariffs of up to 200% on medicines are raising investor concerns.